This is an old revision of this page, as edited by 99.240.100.99 (talk) at 23:11, 17 February 2013. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 23:11, 17 February 2013 by 99.240.100.99 (talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) | This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Pinaverium bromide" – news · newspapers · books · scholar · JSTOR (February 2010) (Learn how and when to remove this message) |
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C26H41BrNO4 |
| Molar mass | 511.51 g/mol g·mol |
| (verify) | |
Pinaverium is a drug used for functional gastrointestinal disorders. It acts as a calcium channel blocker and helps to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and are not designed for immediate symptom relief or sporadic, intermittent use.
| Drugs for functional gastrointestinal disorders (A03) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drugs for functional bowel disorders |
| ||||||||||||
| Belladonna and derivatives (antimuscarinics) |
| ||||||||||||
| Propulsives | |||||||||||||
 | This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it. |